ScoreWhy is Sprint Bioscience AB ?
1
The company has declared negative results for the last 2 consecutive quarters
- The company has declared negative results in Sep 24 after 4 consecutive negative quarters
- PRE-TAX PROFIT(Q) At SEK -5.64 MM has Fallen at -83.63%
- NET PROFIT(Q) At SEK -5.64 MM has Fallen at -83.63%
- RAW MATERIAL COST(Y) Grown by 53.83% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -7.08%, its profits have fallen by -252.4%
3
Underperformed the market in the last 1 year
- Even though the market (OMX Stockholm 30) has generated returns of 8.01% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -7.08% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sprint Bioscience AB for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sprint Bioscience AB
-7.08%
0.11
141.54%
OMX Stockholm 30
8.01%
0.44
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
24.33%
EBIT Growth (5y)
7.54%
EBIT to Interest (avg)
-23.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-5.17
Sales to Capital Employed (avg)
4.31
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
7.10%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.37
EV to EBIT
-2.35
EV to EBITDA
-2.45
EV to Capital Employed
-5.04
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-156.77%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at SEK -9.85 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -517.49 %
-16What is not working for the Company
PRE-TAX PROFIT(Q)
At SEK -5.64 MM has Fallen at -83.63%
NET PROFIT(Q)
At SEK -5.64 MM has Fallen at -83.63%
RAW MATERIAL COST(Y)
Grown by 53.83% (YoY
NET SALES(Q)
Lowest at SEK 14.11 MM
Here's what is working for Sprint Bioscience AB
Debt-Equity Ratio
Lowest at -517.49 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Sprint Bioscience AB
Pre-Tax Profit
At SEK -5.64 MM has Fallen at -83.63%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -5.64 MM has Fallen at -83.63%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Net Sales
Lowest at SEK 14.11 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (SEK MM)
Net Sales
Fallen at -21.05%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (SEK MM)
Raw Material Cost
Grown by 53.83% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
